 | Arcellx, Inc. | |||
| NMS : ACLX || Location: United States | ||||
$54.71+0.27 (+0.5%) |
0.0 M | 54.44 - 54.71 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 3.769 M |
| March 15, 2024 | 3.607 M |
| Feb. 29, 2024 | 3.431 M |
| Feb. 15, 2024 | 3.558 M |
| Jan. 31, 2024 | 3.968 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.62 | 0.42 | 167.40% |
| 09/30/2023 | -0.55 | -0.81 | -46.34% |
| 06/30/2023 | -0.32 | -0.50 | -58.63% |
| 03/31/2023 | 1.86 | -0.58 | -131.21% |
| 12/31/2022 | -0.42 | -0.76 | -78.82% |
ACLX Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 53.290M | Shares Float | 34.162M |
| Short Float | 3.769M | Market Cap | 2901.11M |
| Institution ownership | 90.21% | Insider ownership | 12.801% |
| Earnings Date | 05/08/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -1.47 | Forward EPS | -2.01 |